Literature DB >> 20966180

Pain management in spinal metastases: the role of percutaneous vertebral augmentation.

R H Kassamali1, A Ganeshan2, E T D Hoey1, P M Crowe1, H Douis1, J Henderson1.   

Abstract

Recent technological advances combined with innovative interventional radiology techniques can now offer an alternative less invasive treatment option for many patients with malignant vertebral body infiltration. Percutaneous vertebral augmentation procedures offer less invasive but effective pain relief to many patients with symptomatic spinal metastatic disease. The procedures are image guided and involve the injection of polymethylmethacrylate bone cement into the effected vertebral body. This technique can also be combined with radiofrequency ablation, which may accelerate vertebral stability. In this review, we examine the recent literature surrounding this topic and provide an overview of these emerging techniques.
© The Author 2010. Published by Oxford University Press on behalf of the European Society for Medical Oncology.

Entities:  

Mesh:

Year:  2010        PMID: 20966180     DOI: 10.1093/annonc/mdq605

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


  21 in total

1.  Palliative treatment of bone metastases with samarium-153 EDTMP at onset of pain.

Authors:  Rosj Gallicchio; Sabrina Giacomobono; Anna Nardelli; Teresa Pellegrino; Vittorio Simeon; Domenico Gattozzi; Francesca Maddalena; Pierpaolo Mainenti; Giovanni Storto
Journal:  J Bone Miner Metab       Date:  2014-07       Impact factor: 2.626

Review 2.  Combined Vertebral Augmentation and Radiofrequency Ablation in the Management of Spinal Metastases: an Update.

Authors:  Ning Mao Kam; Julian Maingard; Hong Kuan Kok; Dinesh Ranatunga; Duncan Brooks; William C Torreggiani; Peter L Munk; Michael J Lee; Ronil V Chandra; Hamed Asadi
Journal:  Curr Treat Options Oncol       Date:  2017-11-16

3.  The era of stereotactic body radiotherapy for spinal metastases and the multidisciplinary management of complex cases.

Authors:  Rachit Kumar; Anick Nater; Ahmed Hashmi; Sten Myrehaug; Young Lee; Lijun Ma; Kristin Redmond; Simon S Lo; Eric L Chang; Albert Yee; Charles G Fisher; Michael G Fehlings; Arjun Sahgal
Journal:  Neurooncol Pract       Date:  2015-07-27

4.  Metastatic human breast cancer to the spine produces mechanical hyperalgesia and gait deficits in rodents.

Authors:  Rachel Sarabia-Estrada; Alejandro Ruiz-Valls; Hugo Guerrero-Cazares; Ana M Ampuero; Ismael Jimenez-Estrada; Samantha De Silva; Lydia J Bernhardt; Courtney Rory Goodwin; Ali Karim Ahmed; Yuxin Li; Neil A Phillips; Ziya L Gokaslan; Alfredo Quiñones-Hinojosa; Daniel M Sciubba
Journal:  Spine J       Date:  2017-04-13       Impact factor: 4.166

Review 5.  Interventional Management of Painful Vertebral Body Metastases.

Authors:  Abin Sajan; Ari Isaacson; Sandeep Bagla
Journal:  Semin Intervent Radiol       Date:  2022-06-30       Impact factor: 1.780

Review 6.  Percutaneous Minimally Invasive Techniques in the Treatment of Spinal Metastases.

Authors:  Mara Bozza Stephenson; Bryan Glaenzer; Angelo Malamis
Journal:  Curr Treat Options Oncol       Date:  2016-11

7.  The outcome and survival of palliative surgery in thoraco-lumbar spinal metastases: contemporary retrospective cohort study.

Authors:  R M Nemelc; A Stadhouder; B J van Royen; T U Jiya
Journal:  Eur Spine J       Date:  2014-11       Impact factor: 3.134

8.  Vertebral augmentation for neoplastic lesions with posterior wall erosion and epidural mass.

Authors:  A Cianfoni; E Raz; S Mauri; S Di Lascio; M Reinert; G Pesce; G Bonaldi
Journal:  AJNR Am J Neuroradiol       Date:  2014-09-11       Impact factor: 3.825

Review 9.  [Vertebral stability in management of spinal metastases. Criteria and strategies for operative interventions].

Authors:  B Wiedenhöfer; M Möhlenbruch; S Hemmer; B Lehner; K Klöckner; M Akbar
Journal:  Orthopade       Date:  2012-08       Impact factor: 1.087

Review 10.  Interventional options for the management of refractory cancer pain--what is the evidence?

Authors:  Petra Vayne-Bossert; Banafsheh Afsharimani; Phillip Good; Paul Gray; Janet Hardy
Journal:  Support Care Cancer       Date:  2015-12-11       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.